Jubilant Pharmova schedules investor meets for Feb 9

Jubilant Pharmova announces physical investor/analyst meetings on February 09, 2026 in Mumbai to discuss Q3FY26 earnings with 29 institutional investors at Nuvama India Conference 2026.

Jubilant Pharmova faces ₹22.10 cr tax demand

Jubilant Pharmova received Income Tax Department order raising ₹22.10 crores tax demand for FY2020, citing arithmetical errors and transfer pricing adjustments. Company plans rectification appeal.

Jubilant Pharmova Subsidiary Faces ₹1.73 Cr GST Demand

Jubilant Generics Limited receives GST demand order of ₹1.57 crores plus ₹15.68 lakh penalty from Roorkee GST authorities for erroneously sanctioned refund. Company plans appeal.

Jubilant Pharmova's Subsidiary Receives GST Demand Order Worth Rs 13.77 Crore

Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Pharmova, received an adjudication order from Deputy Commissioner of Commercial Taxes, Mysuru, demanding GST, interest and penalty totaling Rs 13.77 crore for Financial Year 2021-2022 related to Input Tax Credit issues. The company plans to file a detailed appeal contesting the order and expects no financial or operational impact.